Octane Aesthetics Tech Forum: Luvantas CEO

Name: Octane Aesthetics Tech Forum: Luvantas CEO Dives Into Longevity and Aesthetic Medicines Merging
Uploaded: 2025-01-30T10:34:14
Description: Tom Albright, CEO of Luvantas, interviewed Merz Aesthetics CEO Bob Rhatigan during the keynote address at this year’s Octane Aesthetics Tech Forum. Mod

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Octane Aesthetics Tech Forum: Lynch Regenerative Medicine CEO Gives Update on Regenerative Medicine
Octane Aesthetics Tech Forum: Lynch Regenerative Medicine CEO Gives Update on Regenerative Medicine
Octane ATF
Octane Aesthetics Tech Forum: Lynch Regenerative Medicine CEO Gives Update on Regenerative Medicine
Samuel Lynch, DMSc, DMD
Samuel Lynch, DMSc, DMD
Octane Aesthetics Tech Forum: Allergan Aesthetics Vice President Stephanie Manson Brown Discusses Joining Longevity in Aesthetics Panel
Octane Aesthetics Tech Forum: Allergan Aesthetics Vice President Stephanie Manson Brown Discusses Joining Longevity in Aesthetics Panel
Octane ATF
Octane Aesthetics Tech Forum: Allergan Aesthetics Vice President Stephanie Manson Brown Discusses Joining Longevity in Aesthetics Panel
Stephanie Brown, MBBS, MRCS, MFPM
Stephanie Brown, MBBS, MRCS, MFPM
Octane Aesthetics Tech Forum: Dr. Daniel Gould Explains Why You Should Be Offering GLP-1 Treatments in Your Practice
Octane Aesthetics Tech Forum: Dr. Daniel Gould Explains Why You Should Be Offering GLP-1 Treatments in Your Practice
Octane ATF
Octane Aesthetics Tech Forum: Dr. Daniel Gould Explains Why You Should Be Offering GLP-1 Treatments in Your Practice
Daniel Gould, MD, PhD
Daniel Gould, MD, PhD
Octane Aesthetics Tech Forum: Dr. Kay Opens Up About Longevity Medicine’s Future Impact in Aesthetic Industry
Octane Aesthetics Tech Forum: Dr. Kay Opens Up About Longevity Medicine’s Future Impact in Aesthetic Industry
Octane ATF
Octane Aesthetics Tech Forum: Dr. Kay Opens Up About Longevity Medicine’s Future Impact in Aesthetic Industry
Kay Durairaj, MD, FACS
Kay Durairaj, MD, FACS

Octane Aesthetics Tech Forum: Luvantas CEO Dives Into Longevity and Aesthetic Medicines Merging

Recommended

Title

Share on ReachMD

Get a Dose of ModernAesthetics in Your Inbox and Practice Smarter Medicine